Cloning and expression of the cDNA coding for a human lymphocyte IgE receptor

The EMBO Journal (Impact Factor: 10.43). 02/1987; 6(1):109-14.
Source: PubMed


Low-affinity receptors (Fc epsilon R) and secreted factors (IgE-BF) which bind to immunoglobulins of the IgE isotype play a key role in the regulation of human IgE synthesis. We report here the cloning of a cDNA coding for the Fc epsilon R of the human B-lymphoblast cell line RPMI 8866. The nucleotide sequence of this cDNA predicts a polypeptide with 321 amino acids and a mol. wt of 36,281 daltons. A functional Fc epsilon R capable of binding IgE was expressed in Chinese hamster ovary cells after stable transformation with the cDNA which had been cloned into a mammalian expression vector. Amino acid sequence analysis of IgE-BF purified from RPMI 8866 cells revealed an amino-terminal sequence of 19 residues which coincides with the predicted amino acid sequence of the Fc epsilon R, starting at residues 148 and 150. A computer search with the translated amino acid sequence of the Fc epsilon R revealed a domain of 120 amino acids having striking homology to the human asialoglycoprotein receptors.

Full-text preview

Available from:
  • Source
    • "Further, CD23 þ (FceRII) or FceRI þ cells can bind IgE and thus cause considerable false-positive signals in mice undergoing high IgE responses. CD23 is expressed on a wide range of cells including B cells, and binds IgE with low affinity (Ludin et al., 1987). Thus, in animals with high IgE levels, all B cells appear IgE-positive due to binding of IgE to CD23. "
    [Show abstract] [Hide abstract]
    ABSTRACT: IgE antibodies are involved in allergic reactions. High affinity IgE antibodies can cause anaphylaxis when cross-linked by minute amounts of antigen. The issue of how the IgE response is initiated and maintained is addressed in this review. A model has been proposed by which IgE(+) cells expressing antibodies that bind with high affinity to their antigens are generated through an IgG1 intermediate, which goes through affinity maturation in germinal centers (GC) before undergoing sequential switching to IgE. Mice deficient in IgG1 produce IgE at almost normal levels, but the IgE antibodies produced in IgG1-deficient mice lack the antigen-binding strength and the somatic mutations associated with affinity maturation. A GFP reporter strain, which expresses a modified IgE molecule, was recently developed and was utilized to challenge the sequential switching model. Several molecules that are highly expressed in GC can antagonize class switching to IgE in GC antagonize partially class switching to IgE; in addition, GC IgE(+) cells are gradually lost from GC as the immune response progresses, as shown with another recently developed, Venus-expressing IgE reporter mouse strain. In contrast, as a population, IgG1 cells thrive in the GC environment. Membrane IgE-expressing plasmablasts and plasma cells (PC) were recognized as a major component of the IgE response in secondary lymphoid organs. The swift development of IgE cells toward the PC fate, together with the affinity maturation of the IgE response via an IgG intermediate, represent the most salient features of the IgE immune responses, which make them distinct from IgG responses.
    Full-text · Article · Oct 2012 · Advances in Immunology
  • Source
    • "p30A peptide used in this study is a synthetic linear heptapeptide (FHENWPS) obtained by panning a phage displayed peptide M13 library (Ph.D 7, New England BioLabs, Ipswich, MA, USA) on purified sCD23 protein (soluble 25 kDa, kind gift from E. Kilcchher, Novartis, Basel) [35] as detailed elsewhere (PCT Patent 098435). As control (pCtl), we have used synthetic heptapeptide with unrelated sequence (SFNYNYA). "
    [Show abstract] [Hide abstract]
    ABSTRACT: CD23 is a differentiation/activation antigen expressed by a variety of hematopoietic and epithelial cells. It can also be detected in soluble forms in biological fluids. Initially known as the low-affinity receptor for immunoglobulin E (FcεRII), CD23 displays various other physiologic ligands such as CD21, CD11b/c, CD47-vitronectin, and mannose-containing proteins. CD23 mediates numerous immune responses by enhancing IgE-specific antigen presentation, regulating IgE synthesis, influencing cell differentiation and growth of both B- and T-cells. CD23-crosslinking promotes the secretion of pro-inflammatory mediators from human monocytes/macrophages, eosinophils and epithelial cells. Increased CD23 expression is found in patients during allergic reactions and rheumatoid arthritis while its physiopathologic role in these diseases remains to be clarified.
    Full-text · Article · Feb 2009 · PLoS ONE
  • Source
    • "The majority of " inside-out " membrane proteins are cell surface-receptor or ligand proteins. These include CD40L (Hollenbaugh et al. 1992), CD26 (Hegen et al. 1990; Tanaka et al. 1992), CD23 (Ikuta et al. 1987; Ludin et al. 1987), NKR-P1 (Yokoyama and Seaman 1993), and FasL (Suda et al. 1993). DMC1 has the " Pro-Pro-X-Pro " motif near the transmembrane domain. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Frequent allelic losses within chromosomal band 17q25.1 in a variety of human cancers have suggested the presence of one or more tumor suppressor genes in this region. Furthermore, a genetic locus responsible for familial focal nonepidermolytic palmoplantar keratoderma, a condition associated with cancer of the esophagus, lies in the same region. This esophageal-cancer susceptibility locus, TOC (tylosis with oesophageal cancer), might be a target of deletions at 17q25.1 in multiple types of malignancy. Using the reverse transcriptase-polymerase chain reaction (RT-PCR) to examine cancer cell lines for alterations in the expression of transcripts from this portion of 17q, we identified a novel gene that we designated DMC1 (downregulated in multiple cancer-1). The full-length cDNA is 3293bp long. Its putative product is an integral membrane protein of 788 amino acids, belonging to the class of so-called 'inside-out" membrane proteins; it lacks a signal sequence but contains an N-terminal cytoplasmic domain, a single transmembrane peptide, and a C-terminal extracellular domain. We documented loss of expression of DMC1 in 2 of 10 breast-cancer cell lines, in 7 of 10 cervical-cancer lines, in 7 of 13 hepatocellular-cancer lines, in 3 of 7 lung-cancer lines, in 3 of 6 thyroid-cancer lines, in 2 of 6 gastric-cancer lines, and in 2 of 4 renal cell-cancer lines. Our results suggest that loss of expression of the DMC1 gene at 17q25.1 may play an important role in the development of cancers in a broad range of human tissues.
    Full-text · Article · Feb 2001 · Journal of Human Genetics
Show more